Form 4: GoodRx Holdings Executive Romin Nabiey Reports Stock Transactions
SEC Form 4
Romin Nabiey, Chief Accounting Officer of GoodRx Holdings, reports the vesting and subsequent tax withholding of shares of Class A Common Stock.
Summary
- On May 15, 2025, Romin Nabiey, the Chief Accounting Officer of GoodRx Holdings, Inc., reported transactions involving Class A Common Stock.
- These transactions included the vesting of 4,804 restricted stock units and the withholding of 1,719 shares to cover tax obligations.
- Following these transactions, Nabiey directly owns 118,091 shares of Class A Common Stock and 72,062 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions, with no inherent positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common among publicly traded companies.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they relate to executive compensation and do not significantly alter the company's financial position.
Key Dates
| Date | Description |
|---|---|
| 05/15/2025 | Date of the reported transactions: vesting of restricted stock units and tax withholding. |
Keywords
GoodRx Holdings, GDRX, Romin Nabiey, Form 4, Stock Transaction, Restricted Stock Units, Class A Common Stock, Beneficial Ownership, Chief Accounting Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.